University of Cincinnati Medical Center is pleased to share with you ENT Insights, an educational resource with information on the cutting-edge research, clinical trials, training and innovative treatments that are advancing the field.
As many as 50% of patients with obstructive sleep apnea (OSA) are unable or unwilling to adhere to ongoing continuous positive airway pressure (CPAP) therapy prescribed for the condition, reports David L. Steward, MD, Professor of Otolaryngology at the University of Cincinnati.
Read more →
A variety of topical products are available to surgeons to address postsurgical scarring; however, a consensus opinion about treatment superiority has not been reached.
Read more →Standardized dosing of sublingual immunotherapy remains an area of intense study and Dr. Alfred Sassler and his team at the University of Cincinnati Medical Center expect to contribute to that literature in the near future.
Read more →
Sublingual immunotherapy (SLIT) involves dosing the allergen under the tongue of the patient in controlled amounts, often over a period of several years, in order to increase tolerance to a particular allergen and diminish symptoms brought on by exposure to that allergen.
Read more →
Increasingly, physicians are treating ear diseases locally via injectable medications rather than systemically, with the goal of avoiding side effects that can accompany oral medication treatments.
Read more →Performing auditory brainstem implant surgery is very challenging.
Read more →
